Position history for CITADEL ADVISORS LLC's holdings in LEXEO THERAPEUTICS INC
CITADEL ADVISORS LLC holds 3.8M shares of LXEO (LEXEO THERAPEUTICS INC), worth $22M as of 2026-Q1. The position was increased (+1.6% shares). LXEO represents 0.0% of CITADEL ADVISORS LLC's portfolio.
Current Value
$22M
Current Shares
3.8M
Total Value Change
-$19M
Total Shares Change
+1.3M
Other major holders of LXEO: JANUS HENDERSON GROUP PLC, RA CAPITAL MANAGEMENT, L.P., BlackRock, Inc., ADAGE CAPITAL PARTNERS GP, L.L.C.
Increased |
| 3.8M |
+1.6% |
| $22M |
| 0.0% |
| $7.07 |
29 |
| 2025-Q4 | Increased | 3.8M | +1.5% | $37.5M | 0.0% | $9.74 | 29 |
| 2025-Q3 | Increased | 3.7M | +3.1% | $24.7M | 0.0% | $6.66 | 29 |
| 2025-Q2 | Increased | 3.6M | +32.5% | $14.5M | 0.0% | $4.12 | 36 |
| 2025-Q1 | Unchanged | 2.7M | 0.0% | $9.5M | 0.0% | $4.10 | 0 |
| 2024-Q4 | Unchanged | 2.7M | 0.0% | $17.9M | 0.0% | $6.54 | 0 |
| 2024-Q3 | Increased | 2.7M | +6.4% | $24.6M | 0.0% | $9.11 | 31 |
| 2024-Q2 | Increased | 2.6M | +2.2% | $41M | 0.0% | $16.04 | 30 |